{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:44:13Z","timestamp":1792788253187,"version":"4.5.0"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T00:00:00Z","timestamp":1740528000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T00:00:00Z","timestamp":1740528000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"SRM Institute of Science & Technology"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trop Med Health"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The Monkeypox virus (MPXV), which causes Monkeypox (Mpox) is an invasive ailment with global implications. MPXV, categorized within the Orthopoxvirus genus, exhibits diverse clades with varying fatality rates. Initially discovered in monkeys and later in humans, the disease predominantly affects regions across West and Central Africa. Clinical manifestations encompass a spectrum from mild flu-like symptoms to severe eruptions. This article aims to give the scientific community a comprehensive overview of Mpox Pathophysiology and delve into the intricate landscape of host immune responses against MPXV infection. It offers crucial insights into the virus's Pathophysiology, spanning its entry, replication, dissemination, and elicited host responses. The immune reaction to Mpox involves innate immunity, B-cell immunity, and T-cell immunity. Moreover, this review underscores the immunological response and resistance mechanisms against MPXV. It also highlights imperative research areas warranting prioritization to devise more efficacious treatments for controlling viral propagation within healthcare systems. In addition, it gives us a look into possible futures that could help the progress of immunotherapies and cutting-edge biotechnological solutions for protecting against MPXV.<\/jats:p>","DOI":"10.1186\/s41182-025-00708-6","type":"journal-article","created":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T23:15:35Z","timestamp":1740525335000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["From pox to protection: understanding Monkeypox pathophysiology and immune resilience"],"prefix":"10.1186","volume":"53","author":[{"given":"Alagammai","family":"Ganesan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thirumalai","family":"Arunagiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suganandhini","family":"Mani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vamsi Ravi","family":"Kumaran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanaka Parvathi","family":"Kannaiah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hemanth Kumar","family":"Chanduluru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,26]]},"reference":[{"key":"708_CR1","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.67872","author":"S Mani","year":"2024","unstructured":"Mani S, Ganesan A, Arunagiri T, Ravi Kumaran V, Kannaiah KP, Vellapandian C, Chanduluru HK. Epidemiology, virology, and mutation landscape of monkeypox virus from past to present. Cureus. 2024. https:\/\/doi.org\/10.7759\/cureus.67872.","journal-title":"Cureus"},{"key":"708_CR2","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1016\/j.jaad.2022.07.007","volume":"87","author":"J Bryer","year":"2022","unstructured":"Bryer J, Freeman EE, Rosenbach M. Monkeypox emerges on a global scale: a historical review and dermatologic primer. J Am Acad Dermatol. 2022;87:1069\u201374. https:\/\/doi.org\/10.1016\/j.jaad.2022.07.007.","journal-title":"J Am Acad Dermatol"},{"key":"708_CR3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2411368","author":"N Ndembi","year":"2025","unstructured":"Ndembi N, Folayan MO, Komakech A, Mercy K, Tessema S, Mbala-Kingebeni P, Ngandu C, Ngongo N, Kaseya J, Abdool Karim SS. Evolving epidemiology of mpox in Africa in 2024. N Engl J Med. 2025. https:\/\/doi.org\/10.1056\/NEJMoa2411368.","journal-title":"N Engl J Med"},{"key":"708_CR4","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1038\/s41577-022-00775-4","volume":"22","author":"F-M Lum","year":"2022","unstructured":"Lum F-M, Torres-Ruesta A, Tay MZ, Lin RTP, Lye DC, R\u00e9nia L, Ng LFP. Monkeypox: disease epidemiology, host immunity and clinical interventions. Nat Rev Immunol. 2022;22:597\u2013613. https:\/\/doi.org\/10.1038\/s41577-022-00775-4.","journal-title":"Nat Rev Immunol"},{"key":"708_CR5","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.jiph.2023.02.003","volume":"16","author":"A Karagoz","year":"2023","unstructured":"Karagoz A, Tombuloglu H, Alsaeed M, Tombuloglu G, AlRubaish AA, Mahmoud A, Smajlovi\u0107 S, \u0106ordi\u0107 S, Rabaan AA, Alsuhaimi E. Monkeypox (Mpox) virus: classification, origin, transmission, genome organization, antiviral drugs, and molecular diagnosis. J Infect Public Health. 2023;16:531\u201341. https:\/\/doi.org\/10.1016\/j.jiph.2023.02.003.","journal-title":"J Infect Public Health"},{"key":"708_CR6","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0010141","volume":"16","author":"EM Bunge","year":"2022","unstructured":"Bunge EM, Hoet B, Chen L, Lienert F, Weidenthaler H, Baer LR, Steffen R. The changing epidemiology of human Monkeypox\u2014a potential threat? A systematic review. PLoS Negl Trop Dis. 2022;16: e0010141. https:\/\/doi.org\/10.1371\/journal.pntd.0010141.","journal-title":"PLoS Negl Trop Dis"},{"key":"708_CR7","doi-asserted-by":"publisher","DOI":"10.1136\/bmjgh-2024-016937","volume":"10","author":"CLJ Ugwu","year":"2025","unstructured":"Ugwu CLJ, Bragazzi NL, Wu J, Kong JD, Asgary A, Orbinski J, Woldegerima WA. Risk factors associated with human Mpox infection: a systematic review and meta-analysis. BMJ Glob Heal. 2025;10: e016937. https:\/\/doi.org\/10.1136\/bmjgh-2024-016937.","journal-title":"BMJ Glob Heal"},{"key":"708_CR8","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2022.1037598","author":"PA Desingu","year":"2022","unstructured":"Desingu PA, Rubeni TP, Sundaresan NR. Evolution of Monkeypox virus from 2017 to 2022: in the light of point mutations. Front Microbiol. 2022. https:\/\/doi.org\/10.3389\/fmicb.2022.1037598.","journal-title":"Front Microbiol"},{"key":"708_CR9","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1016\/S1473-3099(22)00359-0","volume":"22","author":"MUG Kraemer","year":"2022","unstructured":"Kraemer MUG, Tegally H, Pigott DM, Dasgupta A, Sheldon J, Wilkinson E, Schultheiss M, Han A, Oglia M, Marks S, et al. Tracking the 2022 monkeypox outbreak with epidemiological data in real-time. Lancet Infect Dis. 2022;22:941\u20132. https:\/\/doi.org\/10.1016\/S1473-3099(22)00359-0.","journal-title":"Lancet Infect Dis"},{"key":"708_CR10","doi-asserted-by":"publisher","first-page":"102431","DOI":"10.1016\/j.tmaid.2022.102431","volume":"50","author":"WYT Tan","year":"2022","unstructured":"Tan WYT, Wong CS, Ho MZJ, Said Z, Cui L, Lin RTP, Chan M, Vasoo S, Lee VJM, Leo YS. The first imported case of monkeypox in Singapore during the 2022 outbreak\u2014reflections and lessons. Travel Med Infect Dis. 2022;50:102431. https:\/\/doi.org\/10.1016\/j.tmaid.2022.102431.","journal-title":"Travel Med Infect Dis"},{"key":"708_CR11","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1056\/NEJMoa2207323","volume":"387","author":"JP Thornhill","year":"2022","unstructured":"Thornhill JP, Barkati S, Walmsley S, Rockstroh J, Antinori A, Harrison LB, Palich R, Nori A, Reeves I, Habibi MS, et al. Monkeypox virus infection in humans across 16 countries\u2014April\u2013June 2022. N Engl J Med. 2022;387:679\u201391. https:\/\/doi.org\/10.1056\/NEJMoa2207323.","journal-title":"N Engl J Med"},{"key":"708_CR12","doi-asserted-by":"publisher","first-page":"e554","DOI":"10.1016\/S2666-5247(22)00153-7","volume":"3","author":"A Otu","year":"2022","unstructured":"Otu A, Ebenso B, Walley J, Barcel\u00f3 JM, Ochu CL. Global human monkeypox outbreak: atypical presentation demanding urgent public health action. The Lancet Microbe. 2022;3:e554\u20135. https:\/\/doi.org\/10.1016\/S2666-5247(22)00153-7.","journal-title":"The Lancet Microbe"},{"key":"708_CR13","doi-asserted-by":"publisher","first-page":"102481","DOI":"10.1016\/j.tmaid.2022.102481","volume":"50","author":"M Bhattacharya","year":"2022","unstructured":"Bhattacharya M, Chatterjee S, Nag S, Dhama K, Chakraborty C. Designing, characterization, and immune stimulation of a novel multi-epitopic peptide-based potential vaccine candidate against Monkeypox virus through screening its whole genome encoded proteins: an immunoinformatics approach. Travel Med Infect Dis. 2022;50:102481. https:\/\/doi.org\/10.1016\/j.tmaid.2022.102481.","journal-title":"Travel Med Infect Dis"},{"key":"708_CR14","unstructured":"Graham MD, FIDSA F. Monkeypox (Mpox). https:\/\/emedicine.medscape.com\/article\/1134714-overview#showall. Accessed 19 Apr 2023."},{"key":"708_CR15","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.67154","author":"T Arunagiri","year":"2024","unstructured":"Arunagiri T, Ganesan A, Ravi Kumaran V, Mani S, Chanduluru HK, Vellapandian C, Kannaiah KP. Diagnostic strategies in the era of Monkeypox resurgence: a comprehensive analysis. Cureus. 2024. https:\/\/doi.org\/10.7759\/cureus.67154.","journal-title":"Cureus"},{"key":"708_CR16","doi-asserted-by":"publisher","first-page":"522","DOI":"10.3390\/life13020522","volume":"13","author":"F Anwar","year":"2023","unstructured":"Anwar F, Haider F, Khan S, Ahmad I, Ahmed N, Imran M, Rashid S, Ren Z-G, Khattak S, Ji X-Y. Clinical manifestation, transmission, pathogenesis, and diagnosis of Monkeypox virus: a comprehensive review. Life. 2023;13:522. https:\/\/doi.org\/10.3390\/life13020522.","journal-title":"Life"},{"key":"708_CR17","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.3390\/vaccines11081345","volume":"11","author":"S Malik","year":"2023","unstructured":"Malik S, Ahmed A, Ahsan O, Muhammad K, Waheed Y. Monkeypox virus: a comprehensive overview of viral pathology, immune response, and antiviral strategies. Vaccines. 2023;11:1345. https:\/\/doi.org\/10.3390\/vaccines11081345.","journal-title":"Vaccines"},{"key":"708_CR18","doi-asserted-by":"publisher","first-page":"2067","DOI":"10.1038\/s41564-023-01489-6","volume":"8","author":"P Li","year":"2023","unstructured":"Li P, Pachis ST, Xu G, Schraauwen R, Incitti R, de Vries AC, Bruno MJ, Peppelenbosch MP, Alam I, Raymond K, et al. Mpox virus infection and drug treatment modelled in human skin organoids. Nat Microbiol. 2023;8:2067\u201379. https:\/\/doi.org\/10.1038\/s41564-023-01489-6.","journal-title":"Nat Microbiol"},{"key":"708_CR19","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1093\/ije\/17.3.643","volume":"17","author":"PEM Fine","year":"1988","unstructured":"Fine PEM, Jezek Z, Grab B, Dixon H. The transmission potential of Monkeypox virus in human populations. Int J Epidemiol. 1988;17:643\u201350. https:\/\/doi.org\/10.1093\/ije\/17.3.643.","journal-title":"Int J Epidemiol"},{"key":"708_CR20","doi-asserted-by":"publisher","first-page":"102367","DOI":"10.1016\/j.tmaid.2022.102367","volume":"49","author":"M Dhawan","year":"2022","unstructured":"Dhawan M, Emran TB, Islam F. The resurgence of Monkeypox cases: reasons, threat assessment, and possible preventive measures. Travel Med Infect Dis. 2022;49:102367. https:\/\/doi.org\/10.1016\/j.tmaid.2022.102367.","journal-title":"Travel Med Infect Dis"},{"key":"708_CR21","doi-asserted-by":"publisher","DOI":"10.1155\/cjid\/6683501","author":"S Sankar","year":"2025","unstructured":"Sankar S, Balakrishnan P, Yong YK, Raju S, Velu V, Shankar EM, Larsson M. Mpox virus as a global public health emergency: a scoping review. Can J Infect Dis Med Microbiol. 2025. https:\/\/doi.org\/10.1155\/cjid\/6683501.","journal-title":"Can J Infect Dis Med Microbiol"},{"key":"708_CR22","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.imj.2023.11.001","volume":"2","author":"MA Islam","year":"2023","unstructured":"Islam MA, Mumin J, Haque MM, Haque MA, Khan A, Bhattacharya P, Haque MA. Monkeypox virus (MPXV): a brief account of global spread, epidemiology, virology, clinical features, pathogenesis, and therapeutic interventions. Infect Med. 2023;2:262\u201372. https:\/\/doi.org\/10.1016\/j.imj.2023.11.001.","journal-title":"Infect Med"},{"key":"708_CR23","doi-asserted-by":"publisher","DOI":"10.3201\/eid2002.130118","author":"JR Kugelman","year":"2014","unstructured":"Kugelman JR, Johnston SC, Mulembakani PM, Kisalu N, Lee MS, Koroleva G, McCarthy SE, Gestole MC, Wolfe ND, Fair JN, et al. Genomic variability of Monkeypox virus among humans, democratic Republic of the Congo. Emerg Infect Dis. 2014. https:\/\/doi.org\/10.3201\/eid2002.130118.","journal-title":"Emerg Infect Dis"},{"key":"708_CR24","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/j.tim.2008.07.009","volume":"16","author":"KL Roberts","year":"2008","unstructured":"Roberts KL, Smith GL. Vaccinia virus morphogenesis and dissemination. Trends Microbiol. 2008;16:472\u20139. https:\/\/doi.org\/10.1016\/j.tim.2008.07.009.","journal-title":"Trends Microbiol"},{"key":"708_CR25","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1038\/labinvest.3780373","volume":"81","author":"GM Zaucha","year":"2001","unstructured":"Zaucha GM, Jahrling PB, Geisbert TW, Swearengen JR, Hensley L. The pathology of experimental aerosolized monkeypox virus infection in Cynomolgus monkeys (Macaca Fascicularis). Lab Investig. 2001;81:1581\u2013600. https:\/\/doi.org\/10.1038\/labinvest.3780373.","journal-title":"Lab Investig"},{"key":"708_CR26","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/S0140-6736(22)02075-X","volume":"401","author":"O Mitj\u00e0","year":"2023","unstructured":"Mitj\u00e0 O, Ogoina D, Titanji BK, Galvan C, Muyembe J-J, Marks M, Orkin CM. Monkeypox. Lancet. 2023;401:60\u201374. https:\/\/doi.org\/10.1016\/S0140-6736(22)02075-X.","journal-title":"Lancet"},{"key":"708_CR27","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2022-072410","volume":"2022","author":"A Patel","year":"2022","unstructured":"Patel A, Bilinska J, Tam JCH, Da Silva Fontoura D, Mason CY, Daunt A, Snell LB, Murphy J, Potter J, Tuudah CC, Features and Novel Presentations of Human Monkeypox in a Central London Centre during the, et al. Outbreak: descriptive case series. BMJ. 2022;2022: e072410. https:\/\/doi.org\/10.1136\/bmj-2022-072410.","journal-title":"BMJ"},{"key":"708_CR28","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1002\/med.21943","volume":"43","author":"H Tang","year":"2023","unstructured":"Tang H, Zhang A. Human Mpox: biology, epidemiology, therapeutic options, and development of small molecule inhibitors. Med Res Rev. 2023;43:1019\u201337. https:\/\/doi.org\/10.1002\/med.21943.","journal-title":"Med Res Rev"},{"key":"708_CR29","doi-asserted-by":"publisher","first-page":"6819","DOI":"10.1128\/JVI.03726-13","volume":"88","author":"D Byrd","year":"2014","unstructured":"Byrd D, Shepherd N, Lan J, Hu N, Amet T, Yang K, Desai M, Yu Q. Primary human macrophages serve as vehicles for vaccinia virus replication and dissemination. J Virol. 2014;88:6819\u201331. https:\/\/doi.org\/10.1128\/JVI.03726-13.","journal-title":"J Virol"},{"key":"708_CR30","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2024.1360586","author":"E Alakunle","year":"2024","unstructured":"Alakunle E, Kolawole D, Diaz-C\u00e1nova D, Alele F, Adegboye O, Moens U, Okeke MI. A Comprehensive Review of monkeypox virus and Mpox characteristics. Front Cell Infect Microbiol. 2024. https:\/\/doi.org\/10.3389\/fcimb.2024.1360586.","journal-title":"Front Cell Infect Microbiol"},{"key":"708_CR31","doi-asserted-by":"publisher","first-page":"214","DOI":"10.4269\/ajtmh.1972.21.214","volume":"21","author":"J Noble","year":"1972","unstructured":"Noble J, Mack TM, Thomas DB. A prospective study of serum antibody and protection against smallpox. Am J Trop Med Hyg. 1972;21:214\u20138. https:\/\/doi.org\/10.4269\/ajtmh.1972.21.214.","journal-title":"Am J Trop Med Hyg"},{"key":"708_CR32","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0015547","volume":"5","author":"S Keasey","year":"2010","unstructured":"Keasey S, Pugh C, Tikhonov A, Chen G, Schweitzer B, Nalca A, Ulrich RG. Proteomic basis of the antibody response to Monkeypox virus infection examined in cynomolgus macaques and a comparison to human smallpox vaccination. PLoS ONE. 2010;5: e15547. https:\/\/doi.org\/10.1371\/journal.pone.0015547.","journal-title":"PLoS ONE"},{"key":"708_CR33","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1038\/s41392-023-01675-2","volume":"8","author":"J Lu","year":"2023","unstructured":"Lu J, Xing H, Wang C, Tang M, Wu C, Ye F, Yin L, Yang Y, Tan W, Shen L. Mpox (Formerly Monkeypox): pathogenesis, prevention and treatment. Signal Transduct Target Ther. 2023;8:458. https:\/\/doi.org\/10.1038\/s41392-023-01675-2.","journal-title":"Signal Transduct Target Ther"},{"key":"708_CR34","doi-asserted-by":"publisher","DOI":"10.1097\/QCO.0000000000001100","author":"AE Bryant","year":"2025","unstructured":"Bryant AE, Shulman ST. Mpox: emergence following smallpox eradication, ongoing outbreaks and strategies for prevention. Curr Opin Infect Dis. 2025. https:\/\/doi.org\/10.1097\/QCO.0000000000001100.","journal-title":"Curr Opin Infect Dis"},{"key":"708_CR35","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1038\/nm1261","volume":"11","author":"Y Edghill-Smith","year":"2005","unstructured":"Edghill-Smith Y, Golding H, Manischewitz J, King LR, Scott D, Bray M, Nalca A, Hooper JW, Whitehouse CA, Schmitz JE, et al. Smallpox vaccine-induced antibodies are necessary and sufficient for protection against Monkeypox virus. Nat Med. 2005;11:740\u20137. https:\/\/doi.org\/10.1038\/nm1261.","journal-title":"Nat Med"},{"key":"708_CR36","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/j.virs.2024.08.008","volume":"39","author":"D Fang","year":"2024","unstructured":"Fang D, Liu Y, Dou D, Su B. The unique immune evasion mechanisms of the Mpox virus and their implication for developing new vaccines and immunotherapies. Virol Sin. 2024;39:709\u201318. https:\/\/doi.org\/10.1016\/j.virs.2024.08.008.","journal-title":"Virol Sin"},{"key":"708_CR37","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3390\/zoonoticdis5010003","volume":"5","author":"EM Cambaza","year":"2025","unstructured":"Cambaza EM. A review of the molecular understanding of the Mpox virus (MPXV): genomics, immune evasion, and therapeutic targets. Zoonotic Dis. 2025;5:3. https:\/\/doi.org\/10.3390\/zoonoticdis5010003.","journal-title":"Zoonotic Dis"},{"key":"708_CR38","doi-asserted-by":"publisher","first-page":"101102","DOI":"10.1016\/j.nmni.2023.101102","volume":"52","author":"H Guan","year":"2023","unstructured":"Guan H, Gul I, Xiao C, Ma S, Liang Y, Yu D, Liu Y, Liu H, Zhang CY, Li J, et al. Emergence, phylogeography, and adaptive evolution of Mpox virus. New Microbes New Infect. 2023;52:101102. https:\/\/doi.org\/10.1016\/j.nmni.2023.101102.","journal-title":"New Microbes New Infect"},{"key":"708_CR39","doi-asserted-by":"publisher","first-page":"104424","DOI":"10.1016\/j.ebiom.2022.104424","volume":"87","author":"H Li","year":"2023","unstructured":"Li H, Huang Q-Z, Zhang H, Liu Z-X, Chen X-H, Ye L-L, Luo Y. The land-scape of immune response to Monkeypox virus. EBioMedicine. 2023;87:104424. https:\/\/doi.org\/10.1016\/j.ebiom.2022.104424.","journal-title":"EBioMedicine"},{"key":"708_CR40","doi-asserted-by":"publisher","first-page":"215","DOI":"10.3390\/v9080215","volume":"9","author":"D Nichols","year":"2017","unstructured":"Nichols D, De Martini W, Cottrell J. Poxviruses utilize multiple strategies to inhibit apoptosis. Viruses. 2017;9:215. https:\/\/doi.org\/10.3390\/v9080215.","journal-title":"Viruses"},{"key":"708_CR41","doi-asserted-by":"publisher","first-page":"9527","DOI":"10.1128\/JVI.00199-11","volume":"85","author":"RD Estep","year":"2011","unstructured":"Estep RD, Messaoudi I, O\u2019Connor MA, Li H, Sprague J, Barron A, Engelmann F, Yen B, Powers MF, Jones JM, et al. Deletion of the Monkeypox virus inhibitor of complement enzymes locus impacts the adaptive immune response to Monkeypox virus in a nonhuman primate model of infection. J Virol. 2011;85:9527\u201342. https:\/\/doi.org\/10.1128\/JVI.00199-11.","journal-title":"J Virol"},{"key":"708_CR42","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/S0168-1702(01)00332-X","volume":"81","author":"EA Uvarova","year":"2001","unstructured":"Uvarova EA, Shchelkunov SN. Species-specific differences in the structure of orthopoxvirus complement-binding protein. Virus Res. 2001;81:39\u201345. https:\/\/doi.org\/10.1016\/S0168-1702(01)00332-X.","journal-title":"Virus Res"},{"key":"708_CR43","doi-asserted-by":"publisher","first-page":"109108","DOI":"10.1016\/j.clim.2022.109108","volume":"243","author":"A Al-Musa","year":"2022","unstructured":"Al-Musa A, Chou J, LaBere B. The resurgence of a neglected orthopoxvirus: immunologic and clinical aspects of Monkeypox virus infections over the past six decades. Clin Immunol. 2022;243:109108. https:\/\/doi.org\/10.1016\/j.clim.2022.109108.","journal-title":"Clin Immunol"},{"key":"708_CR44","doi-asserted-by":"publisher","DOI":"10.1007\/s00210-024-03385-0","author":"A Ganesan","year":"2024","unstructured":"Ganesan A, Arunagiri T, Mani S, Kumaran VR, Sk G, Elumalai S, Kannaiah KP, Chanduluru HK. Mpox treatment evolution: past milestones, present advances, and future directions. Naunyn Schmiedebergs Arch Pharmacol. 2024. https:\/\/doi.org\/10.1007\/s00210-024-03385-0.","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"708_CR45","doi-asserted-by":"publisher","DOI":"10.1177\/25151355251314339","author":"M Shafaati","year":"2025","unstructured":"Shafaati M, Forghani S, Shahsavand Davoudi A, Samiee R, Mohammadi K, Akbarpour S, Seifi A, Salehi M, Zare M. Current advances and challenges in Mpox vaccine development: a global landscape. Ther Adv Vaccines Immunother. 2025. https:\/\/doi.org\/10.1177\/25151355251314339.","journal-title":"Ther Adv Vaccines Immunother"},{"key":"708_CR46","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1080\/14787210.2020.1819791","volume":"19","author":"AT Russo","year":"2021","unstructured":"Russo AT, Grosenbach DW, Chinsangaram J, Honeychurch KM, Long PG, Lovejoy C, Maiti B, Meara I, Hruby DE. An overview of tecovirimat for smallpox treatment and expanded anti-orthopoxvirus applications. Expert Rev Anti Infect Ther. 2021;19:331\u201344. https:\/\/doi.org\/10.1080\/14787210.2020.1819791.","journal-title":"Expert Rev Anti Infect Ther"},{"key":"708_CR47","doi-asserted-by":"publisher","first-page":"13139","DOI":"10.1128\/JVI.79.20.13139-13149.2005","volume":"79","author":"G Yang","year":"2005","unstructured":"Yang G, Pevear DC, Davies MH, Collett MS, Bailey T, Rippen S, Barone L, Burns C, Rhodes G, Tohan S, et al. An orally bioavailable antipoxvirus compound (ST-246) inhibits extracellular virus formation and protects mice from lethal orthopoxvirus challenge. J Virol. 2005;79:13139\u201349. https:\/\/doi.org\/10.1128\/JVI.79.20.13139-13149.2005.","journal-title":"J Virol"},{"key":"708_CR48","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1093\/infdis\/jiy326","volume":"218","author":"AT Russo","year":"2018","unstructured":"Russo AT, Grosenbach DW, Brasel TL, Baker RO, Cawthon AG, Reynolds E, Bailey T, Kuehl PJ, Sugita V, Agans K, et al. Effects of treatment delay on efficacy of tecovirimat following lethal aerosol monkeypox virus challenge in cynomolgus macaques. J Infect Dis. 2018;218:1490\u20139. https:\/\/doi.org\/10.1093\/infdis\/jiy326.","journal-title":"J Infect Dis"},{"key":"708_CR49","doi-asserted-by":"publisher","first-page":"2091","DOI":"10.3390\/vaccines10122091","volume":"10","author":"AA Saied","year":"2022","unstructured":"Saied AA, Dhawan M, Metwally AA, Fahrni ML, Choudhary P, Choudhary OP. Disease history, pathogenesis, diagnostics, and therapeutics for human Monkeypox disease: a comprehensive review. Vaccines. 2022;10:2091. https:\/\/doi.org\/10.3390\/vaccines10122091.","journal-title":"Vaccines"},{"key":"708_CR50","first-page":"181","volume":"13","author":"S Duraffour","year":"2010","unstructured":"Duraffour S, Andrei G, Snoeck R. Tecovirimat, a P37 envelope protein inhibitor for the treatment of smallpox infection. IDrugs. 2010;13:181\u201391.","journal-title":"IDrugs"},{"key":"708_CR51","doi-asserted-by":"publisher","first-page":"3845","DOI":"10.1128\/AAC.00214-16","volume":"60","author":"S Chou","year":"2016","unstructured":"Chou S, Ercolani RJ, Lanier ER. Novel cytomegalovirus UL54 DNA polymerase gene mutations selected in vitro that confer brincidofovir resistance. Antimicrob Agents Chemother. 2016;60:3845\u20138. https:\/\/doi.org\/10.1128\/AAC.00214-16.","journal-title":"Antimicrob Agents Chemother"},{"key":"708_CR52","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01925-18","author":"JM Chamberlain","year":"2019","unstructured":"Chamberlain JM, Sortino K, Sethna P, Bae A, Lanier R, Bambara RA, Dewhurst S. Cidofovir diphosphate inhibits adenovirus 5 DNA polymerase via both nonobligate chain termination and direct inhibition, and polymerase mutations confer cidofovir resistance on intact virus. 2019. Antimicrob Agents Chemother. https:\/\/doi.org\/10.1128\/AAC.01925-18."},{"key":"708_CR53","doi-asserted-by":"publisher","first-page":"113813","DOI":"10.1016\/j.intimp.2024.113813","volume":"146","author":"S Dutta","year":"2025","unstructured":"Dutta S, Ghosh R, Dasgupta I, Sikdar P, Santra P, Maity D, Pritam M, Lee SG. Monkeypox: a comprehensive review on mutation, transmission, pathophysiology, and therapeutics. Int Immunopharmacol. 2025;146:113813. https:\/\/doi.org\/10.1016\/j.intimp.2024.113813.","journal-title":"Int Immunopharmacol"},{"key":"708_CR54","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.29354","author":"J Cinatl","year":"2024","unstructured":"Cinatl J, Bechtel M, Reus P, Ott M, Rothweiler F, Michaelis M, Ciesek S, Bojkova D. Trifluridine for treatment of Mpox infection in drug combinations in ophthalmic cell models. J Med Virol. 2024. https:\/\/doi.org\/10.1002\/jmv.29354.","journal-title":"J Med Virol"},{"key":"708_CR55","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1093\/infdis\/jiad058","volume":"228","author":"D Akazawa","year":"2023","unstructured":"Akazawa D, Ohashi H, Hishiki T, Morita T, Iwanami S, Kim KS, Jeong YD, Park E-S, Kataoka M, Shionoya K, et al. Potential anti-Mpox virus activity of atovaquone, mefloquine, and molnupiravir, and their potential use as treatments. J Infect Dis. 2023;228:591\u2013603. https:\/\/doi.org\/10.1093\/infdis\/jiad058.","journal-title":"J Infect Dis"},{"key":"708_CR56","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/j.autrev.2012.08.017","volume":"12","author":"LP Cousens","year":"2013","unstructured":"Cousens LP, Tassone R, Mazer BD, Ramachandiran V, Scott DW, De Groot AS. Tregitope update: mechanism of action parallels IVIg. Autoimmun Rev. 2013;12:436\u201343. https:\/\/doi.org\/10.1016\/j.autrev.2012.08.017.","journal-title":"Autoimmun Rev"},{"key":"708_CR57","doi-asserted-by":"publisher","first-page":"937","DOI":"10.3390\/v15040937","volume":"15","author":"P Kumar","year":"2023","unstructured":"Kumar P, Chaudhary B, Yadav N, Devi S, Pareek A, Alla S, Kajal F, Nowrouzi-Kia B, Chattu VK, Gupta MM. Recent advances in research and management of human Monkeypox virus: an emerging global health threat. Viruses. 2023;15:937. https:\/\/doi.org\/10.3390\/v15040937.","journal-title":"Viruses"},{"key":"708_CR58","doi-asserted-by":"publisher","first-page":"106873","DOI":"10.1016\/j.ijsu.2022.106873","volume":"105","author":"OP Choudhary","year":"2022","unstructured":"Choudhary OP, Priyanka, Fahrni ML, Saied AA, Chopra H. Ring vaccination for Monkeypox containment: strategic implementation and challenges. Int J Surg. 2022;105:106873. https:\/\/doi.org\/10.1016\/j.ijsu.2022.106873.","journal-title":"Int J Surg"},{"key":"708_CR59","doi-asserted-by":"publisher","first-page":"106896","DOI":"10.1016\/j.ijsu.2022.106896","volume":"105","author":"H Chopra","year":"2022","unstructured":"Chopra H, Dhawan M, Bibi S, Baig AA, Kushwah AS, Kaur M, Emran T. Bin FDA approved vaccines for Monkeypox: current eminence. Int J Surg. 2022;105:106896. https:\/\/doi.org\/10.1016\/j.ijsu.2022.106896.","journal-title":"Int J Surg"},{"key":"708_CR60","doi-asserted-by":"publisher","first-page":"7009","DOI":"10.1016\/j.vaccine.2006.03.087","volume":"24","author":"J Kenner","year":"2006","unstructured":"Kenner J, Cameron F, Empig C, Jobes DV, Gurwith M. LC16m8: an attenuated smallpox vaccine. Vaccine. 2006;24:7009\u201322. https:\/\/doi.org\/10.1016\/j.vaccine.2006.03.087.","journal-title":"Vaccine"},{"key":"708_CR61","doi-asserted-by":"publisher","first-page":"480","DOI":"10.22034\/jzd.2024.17643","volume":"8","author":"M Ajel","year":"2024","unstructured":"Ajel M, Zeynali P, Behboudi E. Advances in Monkeypox: exploring vaccines and therapeutic drugs for prevention and treatment. J Zoonotic Dis. 2024;8:480\u20137. https:\/\/doi.org\/10.22034\/jzd.2024.17643.","journal-title":"J Zoonotic Dis"},{"key":"708_CR62","doi-asserted-by":"publisher","DOI":"10.1093\/immadv\/ltad020","author":"MM Christodoulidou","year":"2023","unstructured":"Christodoulidou MM, Mabbott NA. Efficacy of smallpox vaccines against Mpox infections in humans. Immunother Adv. 2023. https:\/\/doi.org\/10.1093\/immadv\/ltad020.","journal-title":"Immunother Adv"},{"key":"708_CR63","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/1743-422X-9-5","volume":"9","author":"SC Johnston","year":"2012","unstructured":"Johnston SC, Lin KL, Connor JH, Ruthel G, Goff A, Hensley LE. In vitro inhibition of Monkeypox virus production and spread by interferon-\u03b2. Virol J. 2012;9:5. https:\/\/doi.org\/10.1186\/1743-422X-9-5.","journal-title":"Virol J"},{"key":"708_CR64","doi-asserted-by":"publisher","first-page":"2381","DOI":"10.3390\/v2102381","volume":"2","author":"Y Xiao","year":"2010","unstructured":"Xiao Y, Isaacs SN. Therapeutic vaccines and antibodies for treatment of orthopoxvirus infections. Viruses. 2010;2:2381\u2013403. https:\/\/doi.org\/10.3390\/v2102381.","journal-title":"Viruses"},{"key":"708_CR65","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1016\/j.cell.2016.09.049","volume":"167","author":"I Gilchuk","year":"2016","unstructured":"Gilchuk I, Gilchuk P, Sapparapu G, Lampley R, Singh V, Kose N, Blum DL, Hughes LJ, Satheshkumar PS, Townsend MB, et al. Cross-neutralizing and protective human antibody specificities to poxvirus infections. Cell. 2016;167:684-694.e9. https:\/\/doi.org\/10.1016\/j.cell.2016.09.049.","journal-title":"Cell"},{"key":"708_CR66","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/j.omtn.2022.05.025","volume":"28","author":"EM Mucker","year":"2022","unstructured":"Mucker EM, Thiele-Suess C, Baumhof P, Hooper JW. Lipid nanoparticle delivery of unmodified MRNAs encoding multiple monoclonal antibodies targeting poxviruses in rabbits. Mol Ther Nucleic Acids. 2022;28:847\u201358. https:\/\/doi.org\/10.1016\/j.omtn.2022.05.025.","journal-title":"Mol Ther Nucleic Acids"},{"key":"708_CR67","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.0040030","volume":"4","author":"M Fang","year":"2008","unstructured":"Fang M, Lanier LL, Sigal LJ. A role for NKG2D in NK cell-mediated resistance to poxvirus disease. PLoS Pathog. 2008;4: e30. https:\/\/doi.org\/10.1371\/journal.ppat.0040030.","journal-title":"PLoS Pathog"},{"key":"708_CR68","doi-asserted-by":"publisher","first-page":"105392","DOI":"10.1016\/j.ebiom.2024.105392","volume":"109","author":"T Kong","year":"2024","unstructured":"Kong T, Du P, Ma R, Wang H, Ma X, Lu J, Gao Z, Qi H, Li R, Zhang H, et al. Single-chain A35R\u2013M1R-B6R trivalent MRNA vaccines protect mice against both Mpox virus and vaccinia virus. EBioMedicine. 2024;109:105392. https:\/\/doi.org\/10.1016\/j.ebiom.2024.105392.","journal-title":"EBioMedicine"},{"key":"708_CR69","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s13365-023-01118-2","volume":"29","author":"M Zandi","year":"2023","unstructured":"Zandi M, Shafaati M, Shapshak P, Hashemnia SMR. Monkeypox virus replication underlying circadian rhythm networks. J Neurovirol. 2023;29:1\u20137. https:\/\/doi.org\/10.1007\/s13365-023-01118-2.","journal-title":"J Neurovirol"},{"key":"708_CR70","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.4049\/jimmunol.0902469","volume":"184","author":"MD Elftman","year":"2010","unstructured":"Elftman MD, Hunzeker JT, Mellinger JC, Bonneau RH, Norbury CC, Truckenmiller ME. Stress-induced glucocorticoids at the earliest stages of herpes simplex virus-1 infection suppress subsequent antiviral immunity, implicating impaired dendritic cell function. J Immunol. 2010;184:1867\u201375. https:\/\/doi.org\/10.4049\/jimmunol.0902469.","journal-title":"J Immunol"},{"key":"708_CR71","doi-asserted-by":"publisher","first-page":"102946","DOI":"10.1016\/j.autrev.2021.102946","volume":"20","author":"LJ Jara","year":"2021","unstructured":"Jara LJ, L\u00f3pez-Zamora B, Ordo\u00f1ez-Gonz\u00e1lez I, Galaviz-S\u00e1nchez MF, Gutierrez-Melgarejo CI, Saavedra M\u00c1, Vera-Lastra O, Cruz-Dom\u00ednguez MP, Medina G. The immune-neuroendocrine system in COVID-19, advanced age and rheumatic diseases. Autoimmun Rev. 2021;20:102946. https:\/\/doi.org\/10.1016\/j.autrev.2021.102946.","journal-title":"Autoimmun Rev"},{"key":"708_CR72","doi-asserted-by":"publisher","first-page":"500","DOI":"10.3390\/vaccines11030500","volume":"11","author":"S Malik","year":"2023","unstructured":"Malik S, Ahmad T, Ahsan O, Muhammad K, Waheed Y. Recent developments in Mpox prevention and treatment options. Vaccines. 2023;11:500. https:\/\/doi.org\/10.3390\/vaccines11030500.","journal-title":"Vaccines"}],"container-title":["Tropical Medicine and Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41182-025-00708-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s41182-025-00708-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41182-025-00708-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T23:15:42Z","timestamp":1740525342000},"score":1,"resource":{"primary":{"URL":"https:\/\/tropmedhealth.biomedcentral.com\/articles\/10.1186\/s41182-025-00708-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,26]]},"references-count":72,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["708"],"URL":"https:\/\/doi.org\/10.1186\/s41182-025-00708-6","relation":{"references":[{"id-type":"uri","id":"","asserted-by":"subject"}]},"ISSN":["1349-4147"],"issn-type":[{"value":"1349-4147","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,26]]},"assertion":[{"value":"14 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"33"}}